Analysis

J&J Wins Battle Against $417M Talc Award, But War Not Over

Law360, Los Angeles (October 23, 2017, 10:43 PM EDT) -- Johnson & Johnson escaped its $417 million loss in the first California jury trial over the alleged link between J&J’s talcum products and ovarian cancer when a California judge last week tossed the verdict because of insufficient scientific evidence, but experts say that unsettled science and impending appellate review mean the ruling isn’t a deathblow for Golden State talc plaintiffs’ hopes.

On Friday, Los Angeles Superior Court Judge Maren E. Nelson issued a 51-page opinion firmly siding with J&J in multiple post-trial motions seeking to scrap since-deceased plaintiff Eva Echeverria’s win in the first case over the alleged talc-ovarian cancer link...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS